• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

去乙酰化酶 SIRT6 通过表观遗传阻断 β-连环蛋白靶基因表达来防止肾脏纤维化。

The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression.

机构信息

Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsha, Hunan, China.

Department of Nephrology, Hunan Key Laboratory of Kidney Disease and Blood Purification, Second Xiangya Hospital at Central South University, Changsha, Hunan, China.

出版信息

Kidney Int. 2020 Jan;97(1):106-118. doi: 10.1016/j.kint.2019.08.028. Epub 2019 Sep 17.

DOI:10.1016/j.kint.2019.08.028
PMID:31787254
Abstract

Fibrosis is a common pathologic pathway of progressive kidney disease involving complex signaling networks. The deacetylase sirtuin 6 (sirt6) was recently implicated in kidney injury. However, it remains elusive whether and how sirt6 contributes to the regulation of kidney fibrosis. Here, we demonstrate that sirt6 protects against kidney interstitial fibrosis through epigenetic regulation of β-catenin signaling. Sirt6 is markedly upregulated during fibrogenesis following obstructed nephropathy and kidney ischemia-reperfusion injury. Pharmacological inhibition of sirt6 deacetylase activity aggravates kidney fibrosis in obstructed nephropathy. Consistently, knockdown of sirt6 in mouse kidney proximal tubular epithelial cells aggravates transforming growth factor-β-induced fibrosis in vitro. Mechanistically, sirt6 deficiency results in augmented expression of the downstream target proteins of β-catenin signaling. We further show that sirt6 interacts with β-catenin during transforming growth factor-β treatment and binds to the promoters of β-catenin target genes, resulting in the deacetylation of histone H3K56 to prevent the transcription of fibrosis-related genes. Thus, our data reveal the anti-fibrotic function of sirt6 by epigenetically attenuating β-catenin target gene expression.

摘要

纤维化是一种涉及复杂信号网络的进行性肾脏疾病的常见病理途径。去乙酰化酶 Sirtuin 6(Sirt6)最近被牵连到肾脏损伤中。然而,Sirt6 是否以及如何参与肾脏纤维化的调节仍然难以捉摸。在这里,我们证明 Sirt6 通过β-catenin 信号的表观遗传调控来防止肾脏间质纤维化。在梗阻性肾病和肾缺血再灌注损伤后的纤维化过程中,Sirt6 明显上调。抑制 Sirt6 去乙酰化酶活性会加重梗阻性肾病中的肾脏纤维化。一致地,在小鼠肾脏近端肾小管上皮细胞中敲低 Sirt6 会加重体外转化生长因子-β诱导的纤维化。在机制上,Sirt6 缺乏会导致β-catenin 信号的下游靶蛋白表达增加。我们进一步表明,Sirt6 在转化生长因子-β处理期间与β-catenin 相互作用,并结合β-catenin 靶基因的启动子,导致组蛋白 H3K56 的去乙酰化,从而阻止纤维化相关基因的转录。因此,我们的数据揭示了 Sirt6 通过表观遗传减弱β-catenin 靶基因表达来发挥抗纤维化功能。

相似文献

1
The deacetylase sirtuin 6 protects against kidney fibrosis by epigenetically blocking β-catenin target gene expression.去乙酰化酶 SIRT6 通过表观遗传阻断 β-连环蛋白靶基因表达来防止肾脏纤维化。
Kidney Int. 2020 Jan;97(1):106-118. doi: 10.1016/j.kint.2019.08.028. Epub 2019 Sep 17.
2
Loss of Proximal Tubular Sirtuin 6 Aggravates Unilateral Ureteral Obstruction-Induced Tubulointerstitial Inflammation and Fibrosis by Regulation of β-Catenin Acetylation.近端肾小管 Sirtuin 6 缺失通过调节 β-连环蛋白乙酰化加重单侧输尿管梗阻诱导的肾小管间质炎症和纤维化。
Cells. 2022 Apr 27;11(9):1477. doi: 10.3390/cells11091477.
3
Phosphorylation by GSK-3β increases the stability of SIRT6 to alleviate TGF-β-induced fibrotic response in renal tubular cells.GSK-3β 磷酸化增加 SIRT6 的稳定性,从而减轻 TGF-β 诱导的肾小管细胞中的纤维反应。
Life Sci. 2022 Nov 1;308:120914. doi: 10.1016/j.lfs.2022.120914. Epub 2022 Aug 31.
4
Sirtuin 6 deficiency transcriptionally up-regulates TGF-β signaling and induces fibrosis in mice.沉默调节蛋白6缺乏在转录水平上上调转化生长因子-β信号通路并诱导小鼠纤维化。
J Biol Chem. 2020 Jan 10;295(2):415-434. doi: 10.1074/jbc.RA118.007212. Epub 2019 Nov 19.
5
Quercetin inhibited the proliferation and invasion of hepatoblastoma cells through facilitating SIRT6-medicated FZD4 silence.槲皮素通过促进 SIRT6 介导的 FZD4 沉默来抑制肝癌细胞的增殖和侵袭。
Hum Exp Toxicol. 2021 Dec;40(12_suppl):S96-S107. doi: 10.1177/09603271211030558. Epub 2021 Jul 5.
6
High glucose-induced oxidative stress represses sirtuin deacetylase expression and increases histone acetylation leading to neural tube defects.高糖诱导的氧化应激会抑制沉默调节蛋白去乙酰化酶的表达,并增加组蛋白乙酰化,从而导致神经管缺陷。
J Neurochem. 2016 May;137(3):371-83. doi: 10.1111/jnc.13587. Epub 2016 Mar 17.
7
SIRT6 Protects Against Liver Fibrosis by Deacetylation and Suppression of SMAD3 in Hepatic Stellate Cells.SIRT6 通过去乙酰化和抑制肝星状细胞中的 SMAD3 来防止肝纤维化。
Cell Mol Gastroenterol Hepatol. 2020;10(2):341-364. doi: 10.1016/j.jcmgh.2020.04.005. Epub 2020 Apr 17.
8
Identification of histone deacetylase 8 as a novel therapeutic target for renal fibrosis.鉴定组蛋白去乙酰化酶 8 为肾纤维化的一个新型治疗靶点。
FASEB J. 2020 Jun;34(6):7295-7310. doi: 10.1096/fj.201903254R. Epub 2020 Apr 12.
9
Sirt6 attenuates hypoxia-induced tubular epithelial cell injury via targeting G2/M phase arrest.Sirt6 通过靶向 G2/M 期阻滞减轻缺氧诱导的肾小管上皮细胞损伤。
J Cell Physiol. 2020 Apr;235(4):3463-3473. doi: 10.1002/jcp.29235. Epub 2019 Oct 11.
10
Sirtuin 6 protects against hepatic fibrogenesis by suppressing the YAP and TAZ function.Sirtuin 6 通过抑制 YAP 和 TAZ 的功能来防止肝纤维化。
FASEB J. 2022 Oct;36(10):e22529. doi: 10.1096/fj.202200522R.

引用本文的文献

1
Liu Wei Di Huang Decoction Alleviates Renal Fibrosis by Inhibiting Endothelial Mesenchymal Transitions via Upregulating Sirt1 Expression and Inhibiting the Wnt/β-Catenin Signaling Pathway.六味地黄丸通过上调Sirt1表达并抑制Wnt/β-连环蛋白信号通路来抑制内皮-间充质转化,从而减轻肾纤维化。
Drug Des Devel Ther. 2025 Jul 30;19:6587-6603. doi: 10.2147/DDDT.S517938. eCollection 2025.
2
The role of macrophages in renal fibrosis and therapeutic prospects.巨噬细胞在肾纤维化中的作用及治疗前景。
PeerJ. 2025 Jul 23;13:e19769. doi: 10.7717/peerj.19769. eCollection 2025.
3
CCN5 negatively regulates TGF-β-induced endometriosis associated fibrosis through Wnt/β-catenin signaling via Smad3-dependent mechanism.

本文引用的文献

1
On the use of corticosteroids for 2019-nCoV pneumonia.关于皮质类固醇在2019新型冠状病毒肺炎中的应用。
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
2
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury.临床证据不支持使用皮质类固醇治疗2019新型冠状病毒肺炎肺损伤。
Lancet. 2020 Feb 15;395(10223):473-475. doi: 10.1016/S0140-6736(20)30317-2. Epub 2020 Feb 7.
3
A pneumonia outbreak associated with a new coronavirus of probable bat origin.一种新型冠状病毒引发的肺炎疫情,该病毒可能来源于蝙蝠。
CCN5通过Smad3依赖性机制,经由Wnt/β-连环蛋白信号通路负向调控转化生长因子-β诱导的子宫内膜异位症相关纤维化。
J Transl Med. 2025 Jul 10;23(1):763. doi: 10.1186/s12967-025-06804-9.
4
Contribution of histone deacetylases (HDACs) to the regulation of histone and non-histone proteins: implications for fibrotic diseases.组蛋白去乙酰化酶(HDACs)对组蛋白和非组蛋白蛋白质调控的贡献:对纤维化疾病的影响。
BMB Rep. 2025 Jul 10.
5
Mechanisms of Acute Kidney Injury-Chronic Kidney Disease Transition: Unraveling Maladaptive Repair and Therapeutic Opportunities.急性肾损伤-慢性肾脏病转化机制:解析适应性不良修复及治疗机遇
Biomolecules. 2025 May 29;15(6):794. doi: 10.3390/biom15060794.
6
Friend or foe? The role of SIRT6 on macrophage polarized to M2 subtype in acute kidney injury to chronic kidney disease.敌友难辨?SIRT6在急性肾损伤向慢性肾病转变过程中对极化至M2亚型巨噬细胞的作用
Ren Fail. 2025 Dec;47(1):2482121. doi: 10.1080/0886022X.2025.2482121. Epub 2025 Apr 22.
7
Sirtuins and Resveratrol in Cardiorenal Diseases: A Narrative Review of Mechanisms and Therapeutic Potential.心脏肾脏疾病中的沉默调节蛋白和白藜芦醇:机制与治疗潜力的叙述性综述
Nutrients. 2025 Mar 30;17(7):1212. doi: 10.3390/nu17071212.
8
Sirtuins in kidney homeostasis and disease: where are we now?肾脏稳态与疾病中的沉默调节蛋白:我们目前的进展如何?
Front Endocrinol (Lausanne). 2025 Jan 22;15:1524674. doi: 10.3389/fendo.2024.1524674. eCollection 2024.
9
The Role of Sirtuins in Diabetic Nephropathy: A Comprehensive Review.沉默调节蛋白在糖尿病肾病中的作用:综述
Curr Protein Pept Sci. 2025;26(6):407-421. doi: 10.2174/0113892037340795241202044932.
10
Suppressing SENP1 inhibits esophageal squamous carcinoma cell growth via SIRT6 SUMOylation.抑制SENP1通过SIRT6的SUMO化抑制食管鳞状癌细胞生长。
Cell Oncol (Dordr). 2025 Feb;48(1):67-81. doi: 10.1007/s13402-024-00956-4. Epub 2024 Jul 2.
Nature. 2020 Mar;579(7798):270-273. doi: 10.1038/s41586-020-2012-7. Epub 2020 Feb 3.
4
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征:描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
5
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
6
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
7
Management of patients at risk of acute kidney injury.急性肾损伤风险患者的管理。
Lancet. 2017 May 27;389(10084):2139-2151. doi: 10.1016/S0140-6736(17)31329-6.
8
Upper Respiratory Tract Infection among Dialysis Patients.透析患者的上呼吸道感染
Isr Med Assoc J. 2016 Sep;18(9):557-560.
9
The clinical and economic burden of pneumonia in patients enrolled in Medicare receiving dialysis: a retrospective, observational cohort study.接受透析的医疗保险参保患者肺炎的临床和经济负担:一项回顾性观察队列研究。
BMC Nephrol. 2016 Dec 12;17(1):199. doi: 10.1186/s12882-016-0412-6.
10
Epidemiology and outcomes of acute kidney injury in elderly chinese patients: a subgroup analysis from the EACH study.中国老年患者急性肾损伤的流行病学及预后:一项来自急性肾损伤中国研究(EACH研究)的亚组分析
BMC Nephrol. 2016 Sep 29;17(1):136. doi: 10.1186/s12882-016-0351-2.